# Tirzepatide Ketoacidosis Case Report in a Woman Without Diabetes | Buy This GLP

A medication safety case describes vomiting, abdominal pain and ketoacidosis after a first tirzepatide injection. One report cannot estimate the risk.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/tirzepatide-ketoacidosis-case
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Safety

# Tirzepatide Ketoacidosis Case Report in a Woman Without Diabetes

One case report describes ketoacidosis after a first tirzepatide injection in a woman without diabetes.

Editorial profile: [Neil Sanders](https://buythisglp.com/authors/neil-sanders)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20265 min readUpdated November 2026

Tirzepatide case report · Presentation six days after first injection · Hospital recovery reported within 48 hours

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

Digestive symptoms are among the [reported side effects of GLP-1 drugs](https://buythisglp.com/research/what-are-the-side-effects-of-a-glp1), and persistent vomiting deserves prompt assessment. This case report describes ketoacidosis in a woman without diabetes after her first tirzepatide injection [\[1\]](https://buythisglp.com/research/tirzepatide-ketoacidosis-case#ref-1).

## What clinicians reported

A woman in her early thirties presented six days after her first injection. She had persistent vomiting, upper abdominal pain and fatigue. Testing showed elevated ketones, metabolic acidosis and mildly low blood sugar [\[1\]](https://buythisglp.com/research/tirzepatide-ketoacidosis-case#ref-1).

She needed hospital treatment and recovered within 48 hours. The authors described reduced food intake as a possible contributor. One report cannot establish how often this happens or prove tirzepatide was the sole cause.

## When to seek medical help

The Zepbound label advises prompt contact with a health care provider for persistent vomiting or other symptoms that can lead to dehydration [\[2\]](https://buythisglp.com/research/tirzepatide-ketoacidosis-case#ref-2). Severe, persistent abdominal pain needs immediate medical attention.

## Frequently asked

Does this report show how often ketoacidosis occurs?

A single report cannot estimate how often it occurs. Persistent vomiting or severe abdominal pain warrants prompt medical attention.

## Sources

1.  \[1\] Sadiq H, et al. (2026). When Weight Loss Turns Dangerous: A Case Report of Tirzepatide-Induced Ketoacidosis in a Non-diabetic Woman Cureus. [PMID 42639616](https://pmc.ncbi.nlm.nih.gov/articles/PMC13503014/)
2.  \[2\] Eli Lilly and Company (2026). Zepbound (tirzepatide) prescribing information DailyMed, U.S. National Library of Medicine. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)

## More in Safety

-   [
    
    Follow the prescription · Storefront → pharmacy → label
    
    ### How to Verify an Online Pharmacy for GLP-1 Medication
    
    ](https://buythisglp.com/research/how-to-verify-online-pharmacy-for-glp1)
-   [
    
    Warm delivery? Pause first. · Save the evidence. Call the pharmacy.
    
    ### Semaglutide Arrived Warm? What to Do Before Using It
    
    ](https://buythisglp.com/research/semaglutide-arrived-warm)
-   [
    
    503A pharmacy · 503B facility · Prescription · per patient · or office stock · CGMP · exempt · required · Oversight · state license · FDA, risk-based · Adverse events · no FDA duty · must report · FDA approval · no · no
    
    ### 503A vs 503B Pharmacy Rules for Compounded GLP-1s
    
    ](https://buythisglp.com/research/503a-vs-503b-pharmacy-compounded-glp1)
